Literature DB >> 12411231

Frontal white matter microstructure and treatment response of late-life depression: a preliminary study.

George S Alexopoulos1, Dimitris N Kiosses, Steven J Choi, Christopher F Murphy, Kelvin O Lim.   

Abstract

OBJECTIVE: This study tested the hypothesis that microstructural abnormalities in white matter areas of the brain containing frontostriatal tracts are associated with a low rate of remission of geriatric depression.
METHOD: Thirteen older patients with major depression received open, but controlled, treatment with citalopram at a target daily dose of 40 mg for 12 weeks. Diffusion tensor imaging was used to determine fractional anisotropy in preselected white matter regions.
RESULTS: Survival analysis with Cox's proportional hazards model revealed that lower fractional anisotropy of the right and the left frontal white matter regions 15 mm above the anterior commissure-posterior commissure plane was associated with a low remission rate after age was considered. Remission was not significantly associated with fractional anisotropy of lower frontal regions or a temporal region.
CONCLUSIONS: Microstructural white matter abnormalities lateral to the anterior cingulate may be associated with a low rate of remission of geriatric depression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411231     DOI: 10.1176/appi.ajp.159.11.1929

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  94 in total

Review 1.  MRI studies in late-life mood disorders.

Authors:  Carmen Andreescu; Howard Aizenstein
Journal:  Curr Top Behav Neurosci       Date:  2012

2.  BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.

Authors:  George S Alexopoulos; Charles E Glatt; Matthew J Hoptman; Dora Kanellopoulos; Christopher F Murphy; Robert E Kelly; Sarah S Morimoto; Kelvin O Lim; Faith M Gunning
Journal:  J Affect Disord       Date:  2010-03-25       Impact factor: 4.839

Review 3.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

4.  Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunction.

Authors:  R Scott Mackin; J Craig Nelson; Kevin L Delucchi; Patrick J Raue; Derek D Satre; Dimitris N Kiosses; George S Alexopoulos; Patricia A Arean
Journal:  Am J Geriatr Psychiatry       Date:  2014-02-26       Impact factor: 4.105

5.  Protein binding in patients with late-life depression.

Authors:  Anand Kumar; Vladimir Kepe; Jorge R Barrio; Prabha Siddarth; Vicki Manoukian; Virginia Elderkin-Thompson; Gary W Small
Journal:  Arch Gen Psychiatry       Date:  2011-11

Review 6.  Diffusion tensor imaging of the brain.

Authors:  Andrew L Alexander; Jee Eun Lee; Mariana Lazar; Aaron S Field
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

7.  Regional differences in diffusion tensor imaging measurements: assessment of intrarater and interrater variability.

Authors:  A Ozturk; A D Sasson; J A D Farrell; B A Landman; A C B S da Motta; A Aralasmak; D M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

8.  Diffuse microstructural abnormalities of normal-appearing white matter in late life depression: a diffusion tensor imaging study.

Authors:  Joshua S Shimony; Yvette I Sheline; Gina D'Angelo; Adrian A Epstein; Tammie L S Benzinger; Mark A Mintun; Robert C McKinstry; Abraham Z Snyder
Journal:  Biol Psychiatry       Date:  2009-04-17       Impact factor: 13.382

9.  Depression in Parkinson's disease. Diffusion tensor imaging study.

Authors:  Hideaki Matsui; Kazuto Nishinaka; Masaya Oda; Hidekazu Niikawa; Kenichi Komatsu; Tamotsu Kubori; Fukashi Udaka
Journal:  J Neurol       Date:  2006-08-20       Impact factor: 4.849

10.  White-matter tract integrity in late-life depression: associations with severity and cognition.

Authors:  R A Charlton; M Lamar; A Zhang; S Yang; O Ajilore; A Kumar
Journal:  Psychol Med       Date:  2013-09-16       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.